Industry: Service & Software
Published Date: 2024-06-15
Pages: 101 Pages
Report ld: 3197258
Request Sample
Customized Report
Pharmaceutical Contract Research Organization (CRO) services refer to outsourced research and development activities that pharmaceutical, biotechnology, and medical device companies delegate to specialized service providers. These CROs offer a broad range of services that support drug development and commercialization.
The global Pharmaceutical CRO Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Pharmaceutical CRO Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pharmaceutical CRO Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Pharmaceutical CRO Services in Commercial is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Pharmaceutical CRO Services include PPD (Thermo Fisher), Space Peptides, Aurigene Pharmaceutical Services, IQVIA, Labcorp Drug Development, Parexel, ICON plc, Syneos Health, Charles River Laboratories, Medpace, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical CRO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical CRO Services.
The Pharmaceutical CRO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical CRO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical CRO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical CRO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical CRO Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Preclinical CRO
1.2.3 Clinical Trial CRO
1.3 Market by Application
1.3.1 Global Pharmaceutical CRO Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Commercial
1.3.3 Scientific Research
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical CRO Services Market Perspective (2019-2030)
2.2 Global Pharmaceutical CRO Services Growth Trends by Region
2.2.1 Global Pharmaceutical CRO Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmaceutical CRO Services Historic Market Size by Region (2019-2024)
2.2.3 Pharmaceutical CRO Services Forecasted Market Size by Region (2025-2030)
2.3 Pharmaceutical CRO Services Market Dynamics
2.3.1 Pharmaceutical CRO Services Industry Trends
2.3.2 Pharmaceutical CRO Services Market Drivers
2.3.3 Pharmaceutical CRO Services Market Challenges
2.3.4 Pharmaceutical CRO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical CRO Services Players by Revenue
3.1.1 Global Top Pharmaceutical CRO Services Players by Revenue (2019-2024)
3.1.2 Global Pharmaceutical CRO Services Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical CRO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical CRO Services Revenue
3.4 Global Pharmaceutical CRO Services Market Concentration Ratio
3.4.1 Global Pharmaceutical CRO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CRO Services Revenue in 2023
3.5 Global Key Players of Pharmaceutical CRO Services Head office and Area Served
3.6 Global Key Players of Pharmaceutical CRO Services, Product and Application
3.7 Global Key Players of Pharmaceutical CRO Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical CRO Services Breakdown Data by Type
4.1 Global Pharmaceutical CRO Services Historic Market Size by Type (2019-2024)
4.2 Global Pharmaceutical CRO Services Forecasted Market Size by Type (2025-2030)
5 Pharmaceutical CRO Services Breakdown Data by Application
5.1 Global Pharmaceutical CRO Services Historic Market Size by Application (2019-2024)
5.2 Global Pharmaceutical CRO Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical CRO Services Market Size (2019-2030)
6.2 North America Pharmaceutical CRO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmaceutical CRO Services Market Size by Country (2019-2024)
6.4 North America Pharmaceutical CRO Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical CRO Services Market Size (2019-2030)
7.2 Europe Pharmaceutical CRO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmaceutical CRO Services Market Size by Country (2019-2024)
7.4 Europe Pharmaceutical CRO Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical CRO Services Market Size (2019-2030)
8.2 Asia-Pacific Pharmaceutical CRO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmaceutical CRO Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmaceutical CRO Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical CRO Services Market Size (2019-2030)
9.2 Latin America Pharmaceutical CRO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmaceutical CRO Services Market Size by Country (2019-2024)
9.4 Latin America Pharmaceutical CRO Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical CRO Services Market Size (2019-2030)
10.2 Middle East & Africa Pharmaceutical CRO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmaceutical CRO Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmaceutical CRO Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PPD (Thermo Fisher)
11.1.1 PPD (Thermo Fisher) Company Details
11.1.2 PPD (Thermo Fisher) Business Overview
11.1.3 PPD (Thermo Fisher) Pharmaceutical CRO Services Introduction
11.1.4 PPD (Thermo Fisher) Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.1.5 PPD (Thermo Fisher) Recent Development
11.2 Space Peptides
11.2.1 Space Peptides Company Details
11.2.2 Space Peptides Business Overview
11.2.3 Space Peptides Pharmaceutical CRO Services Introduction
11.2.4 Space Peptides Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.2.5 Space Peptides Recent Development
11.3 Aurigene Pharmaceutical Services
11.3.1 Aurigene Pharmaceutical Services Company Details
11.3.2 Aurigene Pharmaceutical Services Business Overview
11.3.3 Aurigene Pharmaceutical Services Pharmaceutical CRO Services Introduction
11.3.4 Aurigene Pharmaceutical Services Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.3.5 Aurigene Pharmaceutical Services Recent Development
11.4 IQVIA
11.4.1 IQVIA Company Details
11.4.2 IQVIA Business Overview
11.4.3 IQVIA Pharmaceutical CRO Services Introduction
11.4.4 IQVIA Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.4.5 IQVIA Recent Development
11.5 Labcorp Drug Development
11.5.1 Labcorp Drug Development Company Details
11.5.2 Labcorp Drug Development Business Overview
11.5.3 Labcorp Drug Development Pharmaceutical CRO Services Introduction
11.5.4 Labcorp Drug Development Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.5.5 Labcorp Drug Development Recent Development
11.6 Parexel
11.6.1 Parexel Company Details
11.6.2 Parexel Business Overview
11.6.3 Parexel Pharmaceutical CRO Services Introduction
11.6.4 Parexel Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.6.5 Parexel Recent Development
11.7 ICON plc
11.7.1 ICON plc Company Details
11.7.2 ICON plc Business Overview
11.7.3 ICON plc Pharmaceutical CRO Services Introduction
11.7.4 ICON plc Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.7.5 ICON plc Recent Development
11.8 Syneos Health
11.8.1 Syneos Health Company Details
11.8.2 Syneos Health Business Overview
11.8.3 Syneos Health Pharmaceutical CRO Services Introduction
11.8.4 Syneos Health Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.8.5 Syneos Health Recent Development
11.9 Charles River Laboratories
11.9.1 Charles River Laboratories Company Details
11.9.2 Charles River Laboratories Business Overview
11.9.3 Charles River Laboratories Pharmaceutical CRO Services Introduction
11.9.4 Charles River Laboratories Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.9.5 Charles River Laboratories Recent Development
11.10 Medpace
11.10.1 Medpace Company Details
11.10.2 Medpace Business Overview
11.10.3 Medpace Pharmaceutical CRO Services Introduction
11.10.4 Medpace Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.10.5 Medpace Recent Development
11.11 SGS SA
11.11.1 SGS SA Company Details
11.11.2 SGS SA Business Overview
11.11.3 SGS SA Pharmaceutical CRO Services Introduction
11.11.4 SGS SA Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.11.5 SGS SA Recent Development
11.12 KCR CRO
11.12.1 KCR CRO Company Details
11.12.2 KCR CRO Business Overview
11.12.3 KCR CRO Pharmaceutical CRO Services Introduction
11.12.4 KCR CRO Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.12.5 KCR CRO Recent Development
11.13 TFS HealthScience
11.13.1 TFS HealthScience Company Details
11.13.2 TFS HealthScience Business Overview
11.13.3 TFS HealthScience Pharmaceutical CRO Services Introduction
11.13.4 TFS HealthScience Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.13.5 TFS HealthScience Recent Development
11.14 Caidya
11.14.1 Caidya Company Details
11.14.2 Caidya Business Overview
11.14.3 Caidya Pharmaceutical CRO Services Introduction
11.14.4 Caidya Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.14.5 Caidya Recent Development
11.15 Worldwide Clinical Trials
11.15.1 Worldwide Clinical Trials Company Details
11.15.2 Worldwide Clinical Trials Business Overview
11.15.3 Worldwide Clinical Trials Pharmaceutical CRO Services Introduction
11.15.4 Worldwide Clinical Trials Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.15.5 Worldwide Clinical Trials Recent Development
11.16 CTI
11.16.1 CTI Company Details
11.16.2 CTI Business Overview
11.16.3 CTI Pharmaceutical CRO Services Introduction
11.16.4 CTI Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.16.5 CTI Recent Development
11.17 Advanced Clinical
11.17.1 Advanced Clinical Company Details
11.17.2 Advanced Clinical Business Overview
11.17.3 Advanced Clinical Pharmaceutical CRO Services Introduction
11.17.4 Advanced Clinical Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.17.5 Advanced Clinical Recent Development
11.18 WuXi AppTec
11.18.1 WuXi AppTec Company Details
11.18.2 WuXi AppTec Business Overview
11.18.3 WuXi AppTec Pharmaceutical CRO Services Introduction
11.18.4 WuXi AppTec Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.18.5 WuXi AppTec Recent Development
11.19 Pharmaron Inc.
11.19.1 Pharmaron Inc. Company Details
11.19.2 Pharmaron Inc. Business Overview
11.19.3 Pharmaron Inc. Pharmaceutical CRO Services Introduction
11.19.4 Pharmaron Inc. Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.19.5 Pharmaron Inc. Recent Development
11.20 Hangzhou Tigermed Consulting
11.20.1 Hangzhou Tigermed Consulting Company Details
11.20.2 Hangzhou Tigermed Consulting Business Overview
11.20.3 Hangzhou Tigermed Consulting Pharmaceutical CRO Services Introduction
11.20.4 Hangzhou Tigermed Consulting Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.20.5 Hangzhou Tigermed Consulting Recent Development
11.21 JOINN Laboratories
11.21.1 JOINN Laboratories Company Details
11.21.2 JOINN Laboratories Business Overview
11.21.3 JOINN Laboratories Pharmaceutical CRO Services Introduction
11.21.4 JOINN Laboratories Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.21.5 JOINN Laboratories Recent Development
11.22 MEDICILON
11.22.1 MEDICILON Company Details
11.22.2 MEDICILON Business Overview
11.22.3 MEDICILON Pharmaceutical CRO Services Introduction
11.22.4 MEDICILON Revenue in Pharmaceutical CRO Services Business (2019-2024)
11.22.5 MEDICILON Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Pharmaceutical CRO Services market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 168
USD 4900.00
(Single User License)
The global Pharmaceutical CRO Services market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 116
USD 4250.00
(Single User License)
The global market for Pharmaceutical CRO Services was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 150
USD 3950.00
(Single User License)
The global Pharmaceutical CRO Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 144
USD 2900.00
(Single User License)
The global Pharmaceutical CRO Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 113
USD 4250.00
(Single User License)
The global Pharmaceutical CRO Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 171
USD 4900.00
(Single User License)
The global market for Pharmaceutical CRO Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 146
USD 3950.00
(Single User License)
The global market for Pharmaceutical CRO Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 105
USD 2900.00
(Single User License)
Pharmaceutical Contract Research Organization (CRO) services refer to outsourced research and development activities that pharmaceutical, biotechnology, and medical device companies delegate to specialized service providers. These CROs offer a broad range of services that support drug development and commercialization.
Published Date: 2024-06-15
Pages: 164
USD 4900.00
(Single User License)
Pharmaceutical Contract Research Organization (CRO) services refer to outsourced research and development activities that pharmaceutical, biotechnology, and medical device companies delegate to specialized service providers. These CROs offer a broad range of services that support drug development and commercialization.
Published Date: 2024-06-15
Pages: 142
USD 3950.00
(Single User License)
The global Pharmaceutical CRO Services market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 168
The global Pharmaceutical CRO Services market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 116
The global market for Pharmaceutical CRO Services was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 150
The global Pharmaceutical CRO Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 144
The global Pharmaceutical CRO Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 113
The global Pharmaceutical CRO Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 171
The global market for Pharmaceutical CRO Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 146
The global market for Pharmaceutical CRO Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 105
Pharmaceutical Contract Research Organization (CRO) services refer to outsourced research and development activities that pharmaceutical, biotechnology, and medical device companies delegate to specialized service providers. These CROs offer a broad range of services that support drug development and commercialization.
Published: 2024-06-15
Pages: 164
Pharmaceutical Contract Research Organization (CRO) services refer to outsourced research and development activities that pharmaceutical, biotechnology, and medical device companies delegate to specialized service providers. These CROs offer a broad range of services that support drug development and commercialization.
Published: 2024-06-15
Pages: 142
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now